StoxBox: Buy Aarti Drugs for 16percentage Upside
StoxBox has issued a “Buy” rating for Aarti Drugs Limited, projecting a target price of INR 602, reflecting a 16% upside from the current market price (CMP). This recommendation is…
StoxBox’s 7 Stock Picks: Elevate Your Portfolio Today
In the fast-paced world of stock markets, making well-informed investment decisions can greatly improve your portfolio’s performance. StoxBox has once again showcased its expertise with its latest “Techno Funda” report,…
StoxBox Launches New Brand Campaign: “Brokerage Par Bandh Karo Kharch, Pay Only for Research
June 13, 2024, Mumbai — StoxBox, one of India’s leading value brokers and a subsidiary of BP Wealth, is thrilled to announce the launch of its groundbreaking brand campaign, “Brokerage…
StoxBox: Views on Sun Pharma Industries Ltd. Q4 FY24 Result
The pharma giant reported strong financial results in Q4FY24, supported by robust performance in the US and domestic markets. The revenue growth was majorly led by the US market in…
StoxBox: Research on HCL Technologies
D. K. Mudaraddi, Research Analyst, StoxBox on HCL Technologies Ltd. Q4 FY24. HCL Tech’s Q4FY24 revenue was impacted heavily by the seasonal weakness in the software products business despite the…
StoxBox: Views on UltraTech Cement Q4 FY24 Result
UltraTech Cement showed robust profit growth owing to operating efficiency kicking in and lower energy costs, despite pricing pressure in the industry. Grey cement and white cement volumes recorded double…